GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (OTCPK:SBMFF) » Definitions » Pre-Tax Income

SBMFF (Sino Biopharmaceutical) Pre-Tax Income : $727 Mil (TTM As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sino Biopharmaceutical Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Sino Biopharmaceutical's pretax income for the six months ended in Jun. 2024 was $498 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was $727 Mil. Sino Biopharmaceutical's pretax margin was 22.77%.

During the past 13 years, Sino Biopharmaceutical's highest Pretax Margin was 69.14%. The lowest was 18.30%. And the median was 23.57%.


Sino Biopharmaceutical Pre-Tax Income Historical Data

The historical data trend for Sino Biopharmaceutical's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Pre-Tax Income Chart

Sino Biopharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 766.60 2,915.97 748.01 757.67 724.86

Sino Biopharmaceutical Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 209.46 426.47 329.93 498.16 228.47

Competitive Comparison of Sino Biopharmaceutical's Pre-Tax Income

For the Biotechnology subindustry, Sino Biopharmaceutical's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sino Biopharmaceutical's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Sino Biopharmaceutical's Pre-Tax Income falls into.


;
;

Sino Biopharmaceutical Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Sino Biopharmaceutical's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=810.301+0+-69.359+26.144+-9.417
=758

Sino Biopharmaceutical's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=486.433+0+-21.192+30.856+2.065
=498

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $727 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sino Biopharmaceutical  (OTCPK:SBMFF) Pre-Tax Income Explanation

Sino Biopharmaceutical's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=498.162/2188.154
=22.77%

During the past 13 years, Sino Biopharmaceutical's highest Pretax Margin was 69.14%. The lowest was 18.30%. And the median was 23.57%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sino Biopharmaceutical Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Sino Biopharmaceutical Business Description

Address
1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG
Listed on the Hong Kong Stock Exchange in 2000, Sino Biopharmaceutical is one of the largest Chinese drugmakers. It started with generic drug manufacturing. Since 2018, Sino Biopharm has been actively pivoting into an innovative drugmaker after the Chinese government launched its volume-based procurement policy for the healthcare industry. As of 2023, 37.8% of the firm's total revenue comes from five innovative drugs and five biosimilar drugs. Sino Biopharm's biggest revenue segment is oncology medicines, accounting for 33.6% of total revenue, followed by hepatitis, surgery/analgesia, respiratory, and cardio-cerebral vascular therapeutic areas.

Sino Biopharmaceutical Headlines

From GuruFocus

Value Idea Contest: Sino Biopharmaceutical

By Matthew Sipos Matthew Sipos 01-10-2019

GuruFocus Value Idea Contest Sees 2 Winners!

By Holly LaFon Holly LaFon 07-12-2019

Matthews China Fund Comments on Sino Biopharmaceutical

By Vera Yuan Vera Yuan 10-20-2014

Matthews China Fund Comments on Sino Biopharmaceutical

By Sydnee Gatewood Sydnee Gatewood 01-28-2020

Matthews China Fund 3rd Quarter Commentary

By Holly LaFon Holly LaFon 10-19-2017